Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-03
DOI
10.1038/srep27147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
- (2016) W. Joseph Herring et al. BIOLOGICAL PSYCHIATRY
- Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data
- (2016) Ellen Snyder et al. SLEEP MEDICINE
- Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
- (2014) Anthony J. Roecker et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
- (2014) Anthony L Gotter et al. BMC NEUROSCIENCE
- Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
- (2014) David Michelson et al. LANCET NEUROLOGY
- Perifornical orexinergic neurons modulate REM sleep by influencing locus coeruleus neurons in rats
- (2014) R.C. Choudhary et al. NEUROSCIENCE
- Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs
- (2014) Pamela L. Tannenbaum et al. Frontiers in Behavioral Neuroscience
- Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
- (2014) Christine Dugovic et al. Frontiers in Neuroscience
- The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
- (2013) Anthony L Gotter et al. BMC NEUROSCIENCE
- Discovery of 5′′-Chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3′′-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia
- (2013) Anthony J. Roecker et al. ChemMedChem
- Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
- (2013) Claudia Betschart et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats
- (2013) Steven V Fox et al. NEUROPSYCHOPHARMACOLOGY
- Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors
- (2013) Gabrielle E. Callander et al. Frontiers in Neuroscience
- Distinct effects of IPSU and suvorexant on mouse sleep architecture
- (2013) Daniel Hoyer et al. Frontiers in Neuroscience
- Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
- (2012) P Hoever et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
- (2012) W. J. Herring et al. NEUROLOGY
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep and EEG Power Spectra in a Model of Situational Insomnia
- (2012) Paolo Bettica et al. NEUROPSYCHOPHARMACOLOGY
- Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone
- (2012) Stephen R. Morairty et al. PLoS One
- Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
- (2011) Christopher J. Winrow et al. JOURNAL OF NEUROGENETICS
- Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist
- (2011) Paolo Bettica et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
- (2011) Christopher J. Winrow et al. NEUROPHARMACOLOGY
- Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period
- (2010) Lichao Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
- (2010) Christopher D. Cox et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat
- (2009) C. Dugovic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now